• Smart Pills Market Trends and Forecast: Digital Transformation in Modern Healthcare :
    https://www.theinsightpartners.com/reports/smart-pills-market
    The smart pills market size is projected to reach US$ 13.22 billion by 2031 from US$ 5.01 billion in 2023. The market is expected to register a CAGR of 12.90% during 2023–2031. Remote patient monitoring through smart pills will likely remain a key trend in the market. The market for smart pills will grow even more with increased R&D expenditures. Businesses are developing products, and technological advancements like bioelectronics, microprocessor availability, micro-cameras, and miniaturization are expected to expand the market.
    Smart Pills Market Trends and Forecast: Digital Transformation in Modern Healthcare : https://www.theinsightpartners.com/reports/smart-pills-market The smart pills market size is projected to reach US$ 13.22 billion by 2031 from US$ 5.01 billion in 2023. The market is expected to register a CAGR of 12.90% during 2023–2031. Remote patient monitoring through smart pills will likely remain a key trend in the market. The market for smart pills will grow even more with increased R&D expenditures. Businesses are developing products, and technological advancements like bioelectronics, microprocessor availability, micro-cameras, and miniaturization are expected to expand the market.
    0 Commentaires ·0 Parts ·114 Vue ·0 Avis
  • Global Intelligent Hospital Beds Market Size, Growth Drivers & Insights to 2034

    According to a newly published market research report by 24LifeSciences, global intelligent hospital beds market is valued at USD 2.54 billion in 2026 and is projected to reach USD 4.92 billion by 2034, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period.

    Intelligent hospital beds, a cornerstone of modern healthcare infrastructure, represent a significant evolution from traditional medical beds by integrating advanced technologies within the Internet of Medical Things (IoMT) ecosystem. These smart beds are equipped with sensors that continuously monitor critical patient vital signs including respiration, pulse, and body temperature, transmitting real-time data to central monitoring stations and electronic health records. This capability enables healthcare professionals to perform remote patient monitoring and respond proactively to changes in patient conditions, enhancing both safety and clinical outcomes while addressing staffing efficiency challenges.

    Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10475/intelligent-hospital-beds-market
    Global Intelligent Hospital Beds Market Size, Growth Drivers & Insights to 2034 According to a newly published market research report by 24LifeSciences, global intelligent hospital beds market is valued at USD 2.54 billion in 2026 and is projected to reach USD 4.92 billion by 2034, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period. Intelligent hospital beds, a cornerstone of modern healthcare infrastructure, represent a significant evolution from traditional medical beds by integrating advanced technologies within the Internet of Medical Things (IoMT) ecosystem. These smart beds are equipped with sensors that continuously monitor critical patient vital signs including respiration, pulse, and body temperature, transmitting real-time data to central monitoring stations and electronic health records. This capability enables healthcare professionals to perform remote patient monitoring and respond proactively to changes in patient conditions, enhancing both safety and clinical outcomes while addressing staffing efficiency challenges. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10475/intelligent-hospital-beds-market
    0 Commentaires ·0 Parts ·394 Vue ·0 Avis
  • Why Is the Latin America Wireless Bioimpedance Devices Market Growing at 7.3% CAGR?

    According to 24Chemical Research, the Latin America Wireless Bioimpedance Devices Market is experiencing strong momentum, projected to grow from USD 34 million in 2026 to USD 52 million by 2034, registering a robust CAGR of 7.3% during the forecast period. This growth reflects the region’s accelerating adoption of digital healthcare technologies, rising health awareness, and increasing prevalence of chronic conditions requiring continuous monitoring.

    Wireless bioimpedance devices enable non-invasive assessment of body composition, fluid balance, and tissue characteristics, making them indispensable in both clinical and home-care settings. Their wireless connectivity allows seamless integration with telehealth platforms, cloud-based systems, and remote patient monitoring solutions, aligning well with Latin America’s expanding virtual healthcare ecosystem.

    Brazil leads the regional market with a 45% share, supported by strong private healthcare infrastructure, expanding fitness and wellness programs, and favorable regulatory frameworks. Mexico follows, benefiting from medical tourism growth and close integration with North American healthcare supply chains. Emerging markets such as Argentina, Colombia, and Chile present significant opportunities driven by digital health initiatives and growing chronic disease burdens.

    Key market drivers include rising obesity rates, expanding geriatric populations, and increasing use of bioimpedance in weight management, cardiovascular care, and renal monitoring. Opportunities are expanding through AI-enabled analytics, cloud-connected devices, and corporate wellness programs, while challenges remain in regulatory fragmentation, reimbursement limitations, and economic volatility.

    Overall, the market is positioned for sustained growth as healthcare providers prioritize connected, data-driven, and patient-centric monitoring technologies.

    👉 Get Full Report:
    https://www.24chemicalresearch.com/reports/280656/latin-america-wireless-bioimpedance-devicess-market-market-927

    👉 Download FREE Sample Report:
    https://www.24chemicalresearch.com/download-sample/280656/latin-america-wireless-bioimpedance-devicess-market-market-927

    Company Values

    Data-driven healthcare and medical device insights

    High research accuracy and transparency

    Regulatory-focused market intelligence

    Client-centric strategic analysis

    Global expertise with regional depth

    Contact Details

    24Chemical Research
    📞 International: +1 (332) 2424 294
    📞 Asia: +91 91691 62030
    🌐 Website: https://www.24chemicalresearch.com/

    🔗 LinkedIn: https://www.linkedin.com/company/24chemicalresearch
    Why Is the Latin America Wireless Bioimpedance Devices Market Growing at 7.3% CAGR? According to 24Chemical Research, the Latin America Wireless Bioimpedance Devices Market is experiencing strong momentum, projected to grow from USD 34 million in 2026 to USD 52 million by 2034, registering a robust CAGR of 7.3% during the forecast period. This growth reflects the region’s accelerating adoption of digital healthcare technologies, rising health awareness, and increasing prevalence of chronic conditions requiring continuous monitoring. Wireless bioimpedance devices enable non-invasive assessment of body composition, fluid balance, and tissue characteristics, making them indispensable in both clinical and home-care settings. Their wireless connectivity allows seamless integration with telehealth platforms, cloud-based systems, and remote patient monitoring solutions, aligning well with Latin America’s expanding virtual healthcare ecosystem. Brazil leads the regional market with a 45% share, supported by strong private healthcare infrastructure, expanding fitness and wellness programs, and favorable regulatory frameworks. Mexico follows, benefiting from medical tourism growth and close integration with North American healthcare supply chains. Emerging markets such as Argentina, Colombia, and Chile present significant opportunities driven by digital health initiatives and growing chronic disease burdens. Key market drivers include rising obesity rates, expanding geriatric populations, and increasing use of bioimpedance in weight management, cardiovascular care, and renal monitoring. Opportunities are expanding through AI-enabled analytics, cloud-connected devices, and corporate wellness programs, while challenges remain in regulatory fragmentation, reimbursement limitations, and economic volatility. Overall, the market is positioned for sustained growth as healthcare providers prioritize connected, data-driven, and patient-centric monitoring technologies. 👉 Get Full Report: https://www.24chemicalresearch.com/reports/280656/latin-america-wireless-bioimpedance-devicess-market-market-927 👉 Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/280656/latin-america-wireless-bioimpedance-devicess-market-market-927 Company Values Data-driven healthcare and medical device insights High research accuracy and transparency Regulatory-focused market intelligence Client-centric strategic analysis Global expertise with regional depth Contact Details 24Chemical Research 📞 International: +1 (332) 2424 294 📞 Asia: +91 91691 62030 🌐 Website: https://www.24chemicalresearch.com/ 🔗 LinkedIn: https://www.linkedin.com/company/24chemicalresearch
    0 Commentaires ·0 Parts ·344 Vue ·0 Avis